Key Takeaways
- • Irish SMEs raised just €113.8 million in venture capital in Q3 2026 (July to September), down 45% year on year and a decade low, according to the IVCA's VenturePulse survey.
- • International VCs invested only €35.5 million in Irish SMEs in Q3, a 76% drop, which the IVCA attributes to Ireland's overdependence on foreign investors.
- • Year-to-date funding for the first nine months of 2026 reached €692.2 million, down 19% from the same period in 2025.
- • Deals of €1 million to €5 million fell from 30 last year to 12 this year, signalling a squeeze on mid-sized rounds.
- • Fintech led year-to-date funding at €154.2 million (22% of total), with life sciences at €163.2 million and software at €110.6 million.
Summary
IVCA chairperson Richard Watson said government supports have not resolved the problem. He welcomed Enterprise Ireland's continued support, including through the Seed and Venture Capital Scheme, describing it as welcome in a challenging market, but said its role must sit alongside efforts to attract more private capital and broaden funding options for Irish businesses. The IVCA also flagged a squeeze on mid-sized deals worth between €1 million and €5 million, which fell from 30 last year to 12 this year.
The IVCA attributes the weakness to Ireland's overdependence on foreign investors. International VCs put just €35.5 million into Irish SMEs in the third quarter, a 76% drop.
Year to date, Irish SMEs have raised €692.2 million in venture capital across the first nine months of 2026, down 19% on the same period in 2025. Life sciences businesses attracted the largest share so far at €163.2 million, almost a quarter of the total. Fintech firms raised €154.2 million, or 22% of funding, while software companies raised €110.6 million.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.